BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1464 related articles for article (PubMed ID: 26596890)

  • 1. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
    Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
    Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of anti-CLIC2 and anti-HMGB1 autoantibodies with higher disease activity in systemic lupus erythematosus patients.
    Syahidatulamali CS; Wan Syamimee WG; Azwany YN; Wong KK; Che Maraina CH
    J Postgrad Med; 2017; 63(4):257-261. PubMed ID: 28862243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal anti-nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent-onset disease.
    Frodlund M; Wetterö J; Dahle C; Dahlström Ö; Skogh T; Rönnelid J; Sjöwall C
    Clin Exp Immunol; 2020 Mar; 199(3):245-254. PubMed ID: 31778219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus.
    Schaper F; de Leeuw K; Horst G; Maas F; Bootsma H; Heeringa P; Limburg PC; Westra J
    Clin Exp Immunol; 2017 Jun; 188(3):412-419. PubMed ID: 28245520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
    Pradhan VD; Patwardhan MM; Ghosh K
    Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus.
    Abdulahad DA; Westra J; Bijzet J; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Res Ther; 2011 May; 13(3):R71. PubMed ID: 21548924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [THE CLINICAL INFORMATIVENESS OF AUTOMATED METHODS OF SCREENING DETECTION OF ANTI-NUCLEAR ANTIBODIES USING INDIRECT REACTION OF IMMUNE FLUORESCENCE, ENZYME-LINKED IMMUNOSORBENT ASSAY AND MULTIPLEX XMAP TECHNOLOGY UNDER SYSTEMIC LUPUS ERYTHEMATOSUS].
    Verizhnikova ZG; Aleksandrova EN; Novikov AA; Panafidina TA; Seredavkina NV; Popkova TV; Aizina NL; Nasonov EL
    Klin Lab Diagn; 2017 Mar; 62(3):173-7. PubMed ID: 30620533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden.
    Eriksson C; Kokkonen H; Johansson M; Hallmans G; Wadell G; Rantapää-Dahlqvist S
    Arthritis Res Ther; 2011 Feb; 13(1):R30. PubMed ID: 21342502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay.
    Bremer HD; Lattwein E; Renneker S; Lilliehöök I; Rönnelid J; Hansson-Hamlin H
    Vet Immunol Immunopathol; 2015 Dec; 168(3-4):233-41. PubMed ID: 26547884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-dsDNA antibodies in systemic lupus erythematosus: A combination of two quantitative methods and the ANA pattern is the most efficient strategy of detection.
    Almeida González D; Roces Varela A; Marcelino Rodríguez I; González Vera A; Delgado Sánchez M; Aznar Esquivel A; Casañas Rodríguez C; Cabrera de León A
    J Immunol Methods; 2015 Dec; 427():30-5. PubMed ID: 26407840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-double stranded antibody. Association with titers and fluorescence patterns of anti-nuclear antibody in systemic lupus erythematosus.
    Almogren A
    Saudi Med J; 2010 Jan; 31(1):32-6. PubMed ID: 20062896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International multi-center evaluation of a novel chemiluminescence assay for the detection of anti-dsDNA antibodies.
    Bentow C; Lakos G; Martis P; Wahl E; Garcia M; Viñas O; Espinosa G; Cervera R; Sjöwall C; Carmona-Fernandes D; Santos MJ; Hanly JG; Mahler M
    Lupus; 2016 Jul; 25(8):864-72. PubMed ID: 27252263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune response of IgE antibodies to cellular self-antigens in systemic Lupus Erythematosus.
    Atta AM; Santiago MB; Guerra FG; Pereira MM; Sousa Atta ML
    Int Arch Allergy Immunol; 2010; 152(4):401-6. PubMed ID: 20197682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases].
    Quattrocchi P; Barrile A; Bonanno D; Giannetto L; Patafi M; Tigano V; Ferlazzo B
    Reumatismo; 2005; 57(2):109-13. PubMed ID: 15983634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the result of antinuclear antibody immunofluorescence assay on HEp-2 cells reflect disease activity status in systemic lupus erythematosus.
    Prado MS; Dellavance A; Rodrigues SH; Marvulle V; Andrade LEC
    Clin Chem Lab Med; 2020 Jul; 58(8):1271-1281. PubMed ID: 32623848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modern look at the problems of investigation of antinuclear antibodies in systemic lupus erythematosus (literature review).].
    Aleksandrova EN; Verizhnikova ZG; Novikov AA; Lukina GV
    Klin Lab Diagn; 2018; 63(6):340-348. PubMed ID: 30702224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 74.